ERLIN2
Basic information
Region (hg38): 8:37736601-37758422
Previous symbols: [ "C8orf2", "SPFH2", "SPG18" ]
Links
Phenotypes
GenCC
Source:
- hereditary spastic paraplegia 18 (Moderate), mode of inheritance: AR
- hereditary spastic paraplegia 18 (Strong), mode of inheritance: AR
- hereditary spastic paraplegia 18 (Supportive), mode of inheritance: AR
- juvenile primary lateral sclerosis (Supportive), mode of inheritance: AR
- recessive intellectual disability-motor dysfunction-multiple joint contractures syndrome (Supportive), mode of inheritance: AR
- hereditary spastic paraplegia 18 (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Spastic paraplegia 18A, autosomal dominant; Spastic paraplegia 18B, autosomal recessive | AD/AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 21330303; 23109145; 29528531; 32094424 |
ClinVar
This is a list of variants' phenotypes submitted to
- Spastic_paraplegia (122 variants)
- not_provided (57 variants)
- Inborn_genetic_diseases (25 variants)
- Hereditary_spastic_paraplegia_18 (13 variants)
- not_specified (13 variants)
- Hereditary_spastic_paraplegia (11 variants)
- ERLIN2-related_disorder (5 variants)
- Spastic_paraplegia_18a,_autosomal_dominant (3 variants)
- Abnormality_of_the_nervous_system (1 variants)
- Spastic_paraplegia,_autosomal_dominant (1 variants)
- Spastic_paraparesis (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ERLIN2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000007175.8. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 34 | 39 | ||||
missense | 73 | 88 | ||||
nonsense | 5 | |||||
start loss | 0 | |||||
frameshift | 10 | |||||
splice donor/acceptor (+/-2bp) | 5 | |||||
Total | 20 | 14 | 76 | 35 | 2 |
Highest pathogenic variant AF is 0.0000179697
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ERLIN2 | protein_coding | protein_coding | ENST00000276461 | 11 | 22503 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000667 | 0.981 | 125732 | 0 | 16 | 125748 | 0.0000636 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.88 | 108 | 179 | 0.605 | 0.00000982 | 2243 |
Missense in Polyphen | 41 | 79.171 | 0.51787 | 1001 | ||
Synonymous | 0.350 | 66 | 69.7 | 0.947 | 0.00000441 | 627 |
Loss of Function | 2.08 | 8 | 17.3 | 0.462 | 7.66e-7 | 237 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000210 | 0.000210 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000528 | 0.0000527 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the ERLIN1/ERLIN2 complex which mediates the endoplasmic reticulum-associated degradation (ERAD) of inositol 1,4,5-trisphosphate receptors (IP3Rs) such as ITPR1 (PubMed:19240031, PubMed:17502376). Promotes sterol-accelerated ERAD of HMGCR probably implicating an AMFR/gp78-containing ubiquitin ligase complex (PubMed:21343306). Involved in regulation of cellular cholesterol homeostasis by regulation the SREBP signaling pathway. May promote ER retention of the SCAP-SREBF complex (PubMed:24217618). {ECO:0000269|PubMed:17502376, ECO:0000269|PubMed:19240031, ECO:0000269|PubMed:21343306, ECO:0000269|PubMed:24217618}.;
- Pathway
- Disorders of transmembrane transporters;Disease;Defective CFTR causes cystic fibrosis;Transport of small molecules;ABC-family proteins mediated transport;Signaling by FGFR in disease;Signaling by plasma membrane FGFR1 fusions;FGFR1 mutant receptor activation;Signaling by FGFR1 in disease;ABC transporter disorders;Diseases of signal transduction
(Consensus)
Recessive Scores
- pRec
- 0.116
Intolerance Scores
- loftool
- 0.253
- rvis_EVS
- -0.49
- rvis_percentile_EVS
- 22.09
Haploinsufficiency Scores
- pHI
- 0.323
- hipred
- Y
- hipred_score
- 0.685
- ghis
- 0.613
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.712
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Erlin2
- Phenotype
- skeleton phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- cholesterol metabolic process;peptidyl-tyrosine phosphorylation;ubiquitin-dependent ERAD pathway;SREBP signaling pathway;negative regulation of cholesterol biosynthetic process;negative regulation of fatty acid biosynthetic process;transmembrane transport
- Cellular component
- endoplasmic reticulum;endoplasmic reticulum membrane;cytosol;plasma membrane;integral component of membrane;protein-containing complex;membrane raft
- Molecular function
- protein tyrosine kinase activity;protein binding;cholesterol binding;ubiquitin protein ligase binding